12 бет - Ең жақсы Биопсия дәрігерлері - ЖОҒ-415 дәрігерлер

Дәрігер сүт безі хирургиясына маманданған жоғары тәжірибелі маммолог. Инновациялық хирургиялық әдістерге назар аудара отырып, дәрігер сүт безі хирургиясы бөлімін басқарады, пациенттерге жоғары деңгейде күтім мен нәтижелерді қамтамасыз етеді. Дәрігер сүт безі қатерлі ісігін емдеуге қосқан үлесі үшін танылып, беделді медициналық журналдарда көптеген зерттеу мақалаларын жариялады. Дәрігер сонымен қатар сүт безі қатерлі ісігін емдеуді жақсартуға бағытталған клиникалық сынақтарға қатысады және хирургиялық тәжірибе мен пациенттерге күтім көрсетудегі жетістіктері үшін бірнеше марапаттарға ие болды.<\/p>

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr. Shady Mohammed El‑sebai is an interventional radiologist and diagnostic imaging consultant. He is the Consultant and Chief of Interventional Radiology at Sheaf El Orman Oncology Hospital (2021–present). He is also Chief of the Interventional Radiology Unit at the National Cancer Institute, Cairo University (2022–present). He has been a Lecturer in interventional radiology at the National Cancer Institute since 2018. Earlier posts include assistant lecturer and specialist, radiology resident, specialist at Khartoum Breast Care Centre, and specialist and consultant at Techno Scan.

Expertise includes CT‑ and US‑guided true‑cut biopsies and FNAC; transarterial chemoembolization for HCC and for liver, renal, and soft‑tissue tumors; percutaneous nephrostomy and ureteric stents; pigtail drainage; and RF or microwave ablation of hepatic, bone, lung, and thyroid lesions. He also performs PTD and biliary stents; uterine artery embolization; coiling for pelvic varicosities and varicocele; varicose vein ablation and sclerotherapy; and breast procedures (biopsy, markers, wire localization, Mammotome). He is skilled in US, CT, and MRI.

Дәрігер урология саласында үлкен тәжірибесі бар көрнекті онкохирург. Озық хирургиялық әдістерге маманданған дәрігер урологиялық онкология саласына елеулі үлес қосты. Минималды инвазивті процедураларға назар аудара отырып, дәрігер көптеген күрделі операцияларды сәтті орындап, пациенттердің нәтижелерін жақсартты. Дәрігер сондай-ақ клиникалық зерттеулерге белсенді қатысады, бірнеше рецензияланған жарияланымдарға үлес қосып, халықаралық конференцияларда нәтижелерді ұсынады.<\/p>

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Дәрігер әртүрлі қатерлі ісіктерді емдеуде кең тәжірибесі бар жоғары білікті радиотерапия маманы және онколог болып табылады. Алдыңғы қатарлы радиотерапия әдістеріне маманданған дәрігер инновациялық емдеу жоспарлары арқылы пациенттердің нәтижелерін жақсартуға айтарлықтай үлес қосты. Дәрігер жетекші медициналық кеңестермен аккредиттелген және беделді медициналық журналдарда көптеген ғылыми мақалалар жариялап, онкология саласын жаңашыл жаңалықтармен байытты.<\/p>

Дәрігер қатерлі ісікті емдеуге арналған озық хирургиялық әдістерге маманданған тәжірибелі онкохирург. Бұл салада кең ауқымды тәжірибесі бар дәрігер пациенттердің нәтижелерін жақсартуға бағытталған инновациялық хирургиялық протоколдардың дамуына елеулі үлес қосты. Дәрігер клиникалық жетілдіруге деген адалдығы үшін танылып, беделді медициналық журналдарда көптеген зерттеу мақалаларын жариялады. Профессор ретінде дәрігер келесі буын хирургтарды оқытуға белсенді қатысып, онкохирургияда дәлдік пен пациентке бағытталған күтімнің маңыздылығын атап көрсетеді.<\/p>

Dr. César Lévano Linares is a specialist in general and digestive surgery. He works at Rey Juan Carlos University Hospital and Fundación Jiménez Díaz University Hospital. He is recognized for his work in laparoscopic colorectal surgery.

He holds a PhD in Medicine and Surgery from the Autonomous University of Madrid. He completed a master’s in colorectal and pelvic floor surgery at the University of Zaragoza. He also holds a diploma in laparoscopic surgery from Louis Pasteur University in Strasbourg. He has European accreditation in laparoscopic surgery (EACCME).

His research covers bilateral retroperitoneal hibernoma and conversion from primary endoluminal endoscopic surgery to laparoscopic gastric bypass.

Dr. Son Dong Wan, MD, PhD, is the Chief of Urology at Naeun Hospital. He specializes in urologic oncology, urinary incontinence, sexual dysfunction, and laser prostate surgery. He performs robotic and laparoscopic surgery for cancers of the prostate, bladder, ureter, and kidney. He also treats ureteropelvic junction (UPJ) obstruction.

He earned his PhD from Pusan National University. He completed his internship and residency at Pusan National University Hospital. He is a former Chief at Wallace Memorial Baptist Hospital. He served as a Professor at the Catholic University College of Medicine. He was a Clinical Fellow at Seoul National University Bundang Hospital. He was a Visiting Professor at the University of California, San Diego (UCSD). He completed training in urinary incontinence surgery at the University of Liège.

Awards include the Excellent Paper Award (2007) and the Academic Achievement Award (2014) from the Korean Continence Society. He also received the Best Poster Award from the European Association of Urology (2013).

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Dr. Zohar Dotan is Head of the Urology Department at Sheba Medical Center. He is a leading uro-oncologist and a pioneer of robotic and laparoscopic urologic surgery in Israel.

He has authored more than 50 scientific publications. He is a regular speaker at international conferences. He has received awards from the American Association of Clinical Surgery, including recognition for research in prostate cancer treatment.

Leadership and credentials: Head of the Israeli Uro-Oncology Society. Assistant Professor at Tel Aviv University. Member of the Israeli, American, and European Urological Associations. Training: MD from Tel Aviv University and a PhD in Genetics. Urology residency at Sheba Medical Center. Fellowship in uro-oncology and laparoscopic surgery at Memorial Sloan Kettering, New York.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.

He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.

His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.

He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.

Prof. Gil Raviv, MD, PhD, is Director of the Andrology Unit at Sheba Medical Center. He was listed among the Best Doctors in Israel by Forbes in 2024. He is a leading expert in male fertility, sexual medicine, and reconstructive urology.

His primary focus is male infertility and fertility preservation. He performs advanced semen analysis according to WHO standards. He carries out testicular sperm retrieval (TESE, TESA, MESA) and semen cryopreservation. He also provides comprehensive fertility diagnostics with histological analysis.

He is a Professor at Tel Aviv University. He trained in Siena, Rome, and Tel Aviv. He completed a fellowship in infertility and impotence at Erasme Hospital. He received advanced training in reconstructive urethral surgery in Ghent. He is a member of the European Association of Urology, the International Society for Sexual Medicine, and the Israeli Urological Association.

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Дәрігер эндоскопиялық және лапароскопиялық операцияларға маманданған гинеколог. Аз инвазивті хирургиялық әдістерге назар аудара отырып, дәрігер пациенттердің қалпына келуі мен нәтижелерін жақсартатын озық процедураларды орындауда шебер. Дәрігер күрделі гинекологиялық жағдайларды басқаруда үлкен тәжірибеге ие, оңтайлы күтімді қамтамасыз ету үшін заманауи технологияларды пайдаланады.<\/p>